Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
665
datasets available to search
ShareScore release 0.9.0
Dataset results
665 results for “Exons”
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT05767892. IPD Sharing: NO. Countries: 1. Publications: 0.
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT05241873. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy
ClinicalTrials.gov study NCT04447118. IPD Sharing: NO. Countries: 13. Publications: 0.
Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT04044170. IPD Sharing: Not stated. Countries: 2. Publications: 0.
High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation
ClinicalTrials.gov study NCT02404675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
ClinicalTrials.gov study NCT06043817. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC
ClinicalTrials.gov study NCT04322578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations
ClinicalTrials.gov study NCT06054191. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
ClinicalTrials.gov study NCT03175224. IPD Sharing: NO. Countries: 11. Publications: 0.
Bevacizumab Combined With Double Dose Icotinib in Patients With EGFR Exon 21-L858R Mutation
ClinicalTrials.gov study NCT05263947. IPD Sharing: NO. Countries: 1. Publications: 0.
A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2)
ClinicalTrials.gov study NCT05989542. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations
ClinicalTrials.gov study NCT05378763. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.
ClinicalTrials.gov study NCT06281964. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases
ClinicalTrials.gov study NCT04460729. IPD Sharing: YES. Countries: 0. Publications: 0.
Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation
ClinicalTrials.gov study NCT04063462. IPD Sharing: YES. Countries: 1. Publications: 0.
Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping
ClinicalTrials.gov study NCT01385917. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping
ClinicalTrials.gov study NCT01539772. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04974879. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-World Assessment of Clinical Outcomes in Metastatic NSCLC Patients With MET Exon 14 Skipping Mutation and Brain Metastases Treated With Capmatinib
ClinicalTrials.gov study NCT05675683. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical S
ClinicalTrials.gov study NCT07182682. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.